• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眶周和颞外侧激光静脉治疗期间的不适:一项双盲随机对照试验

Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment: A Double-blind Randomized Controlled Trial.

作者信息

Bonaparte James P, Ellis David E

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada; and Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology, University of Toronto, Toronto, Ontario, Canada.

出版信息

Plast Reconstr Surg Glob Open. 2014 Jun 6;2(5):e159. doi: 10.1097/GOX.0000000000000106. eCollection 2014 May.

DOI:10.1097/GOX.0000000000000106
PMID:25289352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4174088/
Abstract

BACKGROUND

Treatments for cosmetically unpleasing periocular and lateral temporal veins are limited. The purpose of this study was to test the hypothesis that the application of topical lidocaine before the cosmetic treatment of periorbital and lateral temporal veins with a neodymium-doped yttrium aluminum garnet (ND:YAG) laser will result in a significant reduction in subjective pain compared with placebo as assessed using a visual analogue scale.

METHODS

Twenty patients who required bilateral treatment of facial veins were randomly assigned to receive either placebo or 30% lidocaine gel applied topically over the veins, a split-body design. Both the investigator and the patient were blinded to the treatment. An ND:YAG laser was used to treat the veins. Patients completed a visual analogue scale to assess the pain on each side of the face. Data were analyzed using nonparametric data testing.

RESULTS

There was a 64.0% reduction in pain on the treatment side compared with the placebo side (P < 0.001). There was no significant difference in patient-assessed subjective efficacy between sides (P = 0.2). Complications were minimal and mild.

CONCLUSIONS

Patients undergoing periorbital and temporal vein ablation using ND:YAG laser should be offered topical lidocaine as the pain levels are moderate. The use of topical 30% lidocaine results in a significant reduction in pain levels.

摘要

背景

对于外观不佳的眶周静脉和颞侧静脉,治疗方法有限。本研究的目的是验证以下假设:与使用视觉模拟量表评估的安慰剂相比,在使用掺钕钇铝石榴石(ND:YAG)激光对眶周静脉和颞侧静脉进行美容治疗前应用局部利多卡因,将使主观疼痛显著减轻。

方法

20例需要对面部静脉进行双侧治疗的患者被随机分配接受安慰剂或在静脉上局部应用30%利多卡因凝胶,采用自身对照设计。研究者和患者均对治疗不知情。使用ND:YAG激光治疗静脉。患者完成视觉模拟量表以评估面部两侧的疼痛。使用非参数数据检验分析数据。

结果

与安慰剂侧相比,治疗侧疼痛减轻了64.0%(P < 0.001)。两侧患者评估的主观疗效无显著差异(P = 0.2)。并发症轻微且少见。

结论

由于疼痛程度为中度,接受使用ND:YAG激光进行眶周和颞静脉消融的患者应使用局部利多卡因。局部应用30%利多卡因可显著降低疼痛程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad2e/4174088/f6d0962f2efb/gox-2-e159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad2e/4174088/a2976d8d8824/gox-2-e159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad2e/4174088/f6d0962f2efb/gox-2-e159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad2e/4174088/a2976d8d8824/gox-2-e159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad2e/4174088/f6d0962f2efb/gox-2-e159-g002.jpg

相似文献

1
Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment: A Double-blind Randomized Controlled Trial.眶周和颞外侧激光静脉治疗期间的不适:一项双盲随机对照试验
Plast Reconstr Surg Glob Open. 2014 Jun 6;2(5):e159. doi: 10.1097/GOX.0000000000000106. eCollection 2014 May.
2
A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.一项关于低能量调Q掺钕钇铝石榴石(1064纳米)激光与低能量调Q紫翠玉激光(755纳米)治疗面部黄褐斑的随机、半脸临床试验。
Lasers Surg Med. 2014 Sep;46(7):531-7. doi: 10.1002/lsm.22263. Epub 2014 Jun 4.
3
Direct comparison of EMLA versus lidocaine for pain control in Nd:YAG 1,064 nm laser hair removal.在Nd:YAG 1064纳米激光脱毛中,EMLA与利多卡因用于疼痛控制的直接比较。
Dermatol Surg. 2005 Apr;31(4):396-8. doi: 10.1111/j.1524-4725.2005.31104.
4
A Dynamically Cooled, Variable Spot-Sized 1,064 nm Neodymium-doped Yttrium Aluminum Garnet Laser as a Treatment Option for Facial Reticular Veins.一种动态冷却、可变光斑尺寸的 1064nm 掺钕钇铝石榴石激光器,作为治疗面部网状静脉的一种选择。
Dermatol Surg. 2021 Jan 1;47(1):76-78. doi: 10.1097/DSS.0000000000002406.
5
Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.1064纳米调Q开关Nd:YAG激光嫩肤联合超声导入维生素C治疗黄褐斑:一项半脸对照研究
Lasers Med Sci. 2015 Jan;30(1):159-63. doi: 10.1007/s10103-014-1608-2. Epub 2014 Jul 30.
6
Two randomized, double-blind, placebo-controlled studies evaluating the S-Caine Peel for induction of local anesthesia before long-pulsed Nd:YAG laser therapy for leg veins.两项随机、双盲、安慰剂对照研究,评估S-Caine Peel在长脉冲Nd:YAG激光治疗腿部静脉前诱导局部麻醉的效果。
Dermatol Surg. 2003 Oct;29(10):1012-8. doi: 10.1046/j.1524-4725.2003.29293.x.
7
Treatment of Periorbital Veins With Long-Pulse Nd:YAG Laser.长脉冲钕:钇铝石榴石激光治疗眶周静脉
J Drugs Dermatol. 2015 Nov;14(11):1360-2.
8
A randomized controlled trial of peeling and aspiration of Elschnig pearls and neodymium: yttrium-aluminium-garnet laser capsulotomy.埃尔施尼格珠体剥除与抽吸术及钕钇铝石榴石激光晶状体囊切开术的随机对照试验
Int J Ophthalmol. 2015 Jun 18;8(3):590-6. doi: 10.3980/j.issn.2222-3959.2015.03.28. eCollection 2015.
9
Comparative effectiveness of purpuragenic 595 nm pulsed dye laser versus sequential emission of 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser: a double-blind randomized controlled study.595纳米紫癜性脉冲染料激光与595纳米脉冲染料激光和1064纳米Nd:YAG激光序贯发射的比较疗效:一项双盲随机对照研究。
Acta Dermatovenerol Alp Pannonica Adriat. 2019 Mar;28(1):1-5.
10
Neodymium-doped yttrium aluminium garnet (Nd:YAG) 1064-nm picosecond laser vs. Nd:YAG 1064-nm nanosecond laser in tattoo removal: a randomized controlled single-blind clinical trial.掺钕钇铝石榴石(Nd:YAG)1064nm 皮秒激光与 Nd:YAG 1064nm 纳秒激光治疗纹身的比较:一项随机对照单盲临床试验。
Br J Dermatol. 2017 Feb;176(2):457-464. doi: 10.1111/bjd.14962. Epub 2017 Jan 29.

引用本文的文献

1
Updates and Best Practices in the Management of Facial Erythema.面部红斑管理的最新进展与最佳实践
Clin Cosmet Investig Dermatol. 2021 Jun 8;14:601-614. doi: 10.2147/CCID.S267203. eCollection 2021.

本文引用的文献

1
Indocyanine green-augmented diode laser therapy vs. long-pulsed Nd:YAG (1064 nm) laser treatment of telangiectatic leg veins: a randomized controlled trial.吲哚菁绿增强二极管激光治疗与长脉冲 Nd:YAG(1064nm)激光治疗毛细血管扩张性腿部静脉:一项随机对照试验。
Br J Dermatol. 2013 Aug;169(2):365-73. doi: 10.1111/bjd.12415.
2
Periorbital rejuvenation: reticular vein treatment.眶周年轻化:网状静脉治疗
Facial Plast Surg Clin North Am. 2013 Feb;21(1):147-55. doi: 10.1016/j.fsc.2012.11.006.
3
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
CONSORT 2010 声明:平行组随机试验报告的更新指南。
Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
4
Vascular lasers and IPLS: guidelines for care from the European Society for Laser Dermatology (ESLD).血管激光和强脉冲光:欧洲激光皮肤病学会(ESLD)的护理指南
J Cosmet Laser Ther. 2007 Jun;9(2):113-24. doi: 10.1080/14764170701280693.
5
Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser.使用动态冷却、光斑大小可变的1064纳米掺钕钇铝石榴石激光治疗面部网状静脉。
J Cosmet Dermatol. 2007 Mar;6(1):6-8. doi: 10.1111/j.1473-2165.2007.00256.x.
6
Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm.使用1064纳米Nd:YAG激光治疗腿部静脉的最佳参数。
Br J Dermatol. 2006 Aug;155(2):364-71. doi: 10.1111/j.1365-2133.2006.07314.x.
7
Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias.可变脉冲钕:钇铝石榴石激光治疗面部毛细血管扩张症
Dermatol Surg. 2006 Jan;32(1):7-12. doi: 10.1111/1524-4725.2006.32001.
8
Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd:YAG laser--a prospective study of 47 patients.使用冷冻喷雾可变脉宽1064纳米钕钇铝石榴石激光治疗腿部和面部静脉——47例患者的前瞻性研究
J Cosmet Laser Ther. 2001 Sep;3(3):147-53. doi: 10.1080/147641701753414960.
9
Removal of blue periocular lower eyelid veins by ambulatory phlebectomy.通过门诊静脉切除术去除眼周下睑蓝色静脉。
Dermatol Surg. 2002 Jan;28(1):43-5. doi: 10.1046/j.1524-4725.2002.01189.x.
10
Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster.正常志愿者、带状疱疹后神经痛患者及急性带状疱疹患者局部应用利多卡因后的全身吸收情况。
J Pharm Sci. 2002 May;91(5):1343-50. doi: 10.1002/jps.10133.